{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:07:51Z","timestamp":1791259671410,"version":"4.1.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":1805,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.bbmt.2010.02.005","type":"journal-article","created":{"date-parts":[[2010,2,11]],"date-time":"2010-02-11T06:54:27Z","timestamp":1265871267000},"page":"565-586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor\/Leukemia Reaction"],"prefix":"10.1016","volume":"16","author":[{"given":"Jeffrey S.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edus H.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel R.M.","family":"van den Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren D.","family":"Shlomchik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Jochem","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H. Frederik","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2010.02.005_bib1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T cell subsets: function, generation, and maintenance","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12026-008-8027-z","article-title":"Intrinsic and extrinsic control of effector T cell survival and memory T cell development","volume":"45","author":"Hand","year":"2009","journal-title":"Immunol Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","article-title":"Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease","volume":"103","author":"Chen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib4","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1182\/blood-2007-08-109678","article-title":"Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease","volume":"111","author":"Zheng","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib5","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.4049\/jimmunol.0802212","article-title":"Central memory CD8+ T cells induce graft-versus-host disease and mediate graft-versus-leukemia","volume":"182","author":"Zheng","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib6","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.0503726102","article-title":"Central memory self\/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells","volume":"102","author":"Klebanoff","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1172\/JCI32103","article-title":"Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates","volume":"118","author":"Berger","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib8","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.1073\/pnas.0907448106","article-title":"Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity","volume":"106","author":"Hinrichs","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib9","doi-asserted-by":"crossref","first-page":"60A","DOI":"10.1182\/blood.V108.11.191.191","article-title":"Mechanisms of GVL against a murine blast crisis CML","volume":"108","author":"Shlomchik","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib10","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2003-10-3735","article-title":"Graft-versus-leukemia in a retrovirally induced murine CML model: mechanisms of T-cell killing","volume":"103","author":"Matte","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib11","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1182\/blood-2007-11-125294","article-title":"CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens, whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL","volume":"111","author":"Matte-Martone","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/nm1309","article-title":"A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses","volume":"11","author":"Reddy","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.immuni.2007.08.007","article-title":"Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection","volume":"27","author":"Kaech","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2010.02.005_bib14","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1182\/blood-2002-05-1299","article-title":"Real-time T-cell profiling identifies H60 as a major minor histocompatibility antigen in murine graft-versus-host disease","volume":"100","author":"Choi","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib15","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib16","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1172\/JCI19427","article-title":"Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model","volume":"112","author":"Jones","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib17","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood-2004-08-3032","article-title":"Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ","volume":"105","author":"Anderson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood-2002-04-1032","article-title":"Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy","volume":"101","author":"Meunier","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2010.02.005_bib21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Le Bon","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib22","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.186.12.2057","article-title":"CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity","volume":"186","author":"Kurts","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib23","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.4049\/jimmunol.175.4.2244","article-title":"Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA","volume":"175","author":"Kuchtey","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ni1082","article-title":"Cellular mechanisms governing cross-presentation of exogenous antigens","volume":"5","author":"Ackerman","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","article-title":"Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens","volume":"199","author":"Heath","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2010.02.005_bib26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2010.02.005_bib27","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.4049\/jimmunol.164.9.4564","article-title":"CD28-specific antibody prevents graft-versus-host disease in mice","volume":"164","author":"Yu","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib28","doi-asserted-by":"crossref","first-page":"14163","DOI":"10.1073\/pnas.2335041100","article-title":"B7h is required for T cell activation, differentiation, and effector function","volume":"100","author":"Nurieva","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/35051100","article-title":"ICOS co-stimulatory receptor is essential for T-cell activation and function","volume":"409","author":"Dong","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2010.02.005_bib30","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2005-01-0410","article-title":"Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation","volume":"106","author":"Hubbard","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib31","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1182\/blood-2004-10-3869","article-title":"Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM)","volume":"105","author":"Taylor","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib32","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.4049\/jimmunol.176.5.2808","article-title":"Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells","volume":"176","author":"Raimondi","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib33","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.4049\/jimmunol.176.12.7394","article-title":"Opposing effects of ICOS on graft-versus-host disease mediated by CD4 and CD8 T cells","volume":"176","author":"Yu","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib34","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.4049\/jimmunol.171.3.1272","article-title":"Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism","volume":"171","author":"Blazar","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib35","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood-2002-10-3048","article-title":"Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients","volume":"101","author":"Blazar","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4049\/jimmunol.158.1.29","article-title":"Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation","volume":"158","author":"Blazar","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib37","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.4049\/jimmunol.162.8.4373","article-title":"Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease","volume":"162","author":"Buhlmann","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib38","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.4049\/jimmunol.160.9.4225","article-title":"Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28","volume":"160","author":"Saito","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib39","first-page":"A818","article-title":"Superior GVHD prevention by combined costimulatory blockade: comparison of single and combined pathway blockade of CD28\/CTLA4:B7, CD40L: CD40 and OX40:OX40L pathways","volume":"100","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib40","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1073\/pnas.86.6.1963","article-title":"cDNA sequences of two inducible T-cell genes","volume":"86","author":"Kwon","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/cimm.1998.1396","article-title":"NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies","volume":"190","author":"Melero","year":"1998","journal-title":"Cell Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib42","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.4049\/jimmunol.167.9.4981","article-title":"Preferential blockade of CD8(+) T cell responses by administration of anti-CD137 ligand monoclonal antibody results in differential effect on development of murine acute and chronic graft-versus-host diseases","volume":"167","author":"Nozawa","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib43","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4049\/jimmunol.166.5.3174","article-title":"Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients","volume":"166","author":"Blazar","year":"2001","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib44","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ni759","article-title":"Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance","volume":"3","author":"Shimizu","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1084\/jem.20040116","article-title":"GITR activation induces an opposite effect on alloreactive CD4(+) and CD8(+) T cells in graft-versus-host disease","volume":"200","author":"Muriglan","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib46","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.20021910","article-title":"Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function","volume":"197","author":"Curtsinger","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib47","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4049\/jimmunol.174.2.600","article-title":"Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells","volume":"174","author":"Valenzuela","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib48","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.4049\/jimmunol.175.7.4392","article-title":"Signal 3 tolerant CD8 T cells degranulate in response to antigen but lack granzyme B to mediate cytolysis","volume":"175","author":"Curtsinger","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib49","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.178.11.6752","article-title":"Signal 3 availability limits the CD8 T cell response to a solid tumor","volume":"178","author":"Curtsinger","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib50","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","article-title":"Leukocyte migration and graft-versus-host disease","volume":"105","author":"Wysocki","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1034\/j.1600-065X.2002.18610.x","article-title":"The immunological synapse: integrins take the stage","volume":"186","author":"Sims","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2010.02.005_bib52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.95.1.258","article-title":"A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes","volume":"95","author":"Gunn","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib53","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3562::AID-IMMU3562>3.0.CO;2-R","article-title":"Distinct migration patterns of naive and effector CD8 T cells in the spleen: correlation with CCR7 receptor expression and chemokine reactivity","volume":"29","author":"Potsch","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib54","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2005-05-1860","article-title":"CCR2 is required for CD8-induced graft-versus-host disease","volume":"106","author":"Terwey","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib55","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood-2003-03-0957","article-title":"LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease","volume":"103","author":"Petrovic","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib56","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2005-08-3445","article-title":"Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine","volume":"107","author":"Waldman","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib57","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa042982","article-title":"Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin","volume":"352","author":"Feagan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib58","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis","volume":"354","author":"Rudick","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib59","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/01.mpg.0000252191.05170.e7","article-title":"Natalizumab therapy for moderate to severe Crohn disease in adolescents","volume":"44","author":"Hyams","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.bbmt.2010.02.005_bib61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/ibd.20014","article-title":"Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab","volume":"13","author":"Sands","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bbmt.2010.02.005_bib62","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.4049\/jimmunol.152.7.3282","article-title":"Role of alpha 4-integrins in lymphocyte homing to mucosal tissues in vivo","volume":"152","author":"Hamann","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nri775","article-title":"Cytolytic pathways in haematopoietic stem-cell transplantation","volume":"2","author":"van den Brink","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib64","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/sj.leu.2403414","article-title":"Prevalence and clinical significance of resistance to perforin- and FAS-mediated cell death in leukemia","volume":"18","author":"Otten","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.02.005_bib65","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1182\/blood.V96.3.1047","article-title":"Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses","volume":"96","author":"Hsieh","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib66","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1084\/jem.183.6.2645","article-title":"The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice","volume":"183","author":"Baker","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1172\/JCI6896","article-title":"Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia","volume":"104","author":"Hill","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib68","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1182\/blood-2005-09-3883","article-title":"Identification of the angiogenic endothelial-cell growth factor-1\/thymidine phosphorylase as a potential target for immunotherapy of cancer","volume":"107","author":"Slager","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib69","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1182\/blood-2006-08-043935","article-title":"Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene","volume":"109","author":"van Bergen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood-2007-02-075911","article-title":"Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen","volume":"110","author":"Kawase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib71","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1172\/JCI24832","article-title":"A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia","volume":"115","author":"de Rijke","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib72","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.20030044","article-title":"A human minor histocompatibility antigen resulting from differential expression due to a gene deletion","volume":"197","author":"Murata","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib73","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.tp.0000259931.72622.d1","article-title":"A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A\u22172902 and -B\u22174403","volume":"83","author":"Terakura","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.02.005_bib74","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1182\/blood-2008-07-171678","article-title":"HapMap scanning of novel human minor histocompatibility antigens","volume":"113","author":"Kamei","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib75","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1182\/blood.V99.8.3027","article-title":"The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease","volume":"99","author":"Vogt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib76","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1073\/pnas.0712250105","article-title":"Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity","volume":"105","author":"Griffioen","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib77","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2009-03-208017","article-title":"Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity","volume":"114","author":"Stumpf","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib78","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1084\/jem.174.1.27","article-title":"Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes","volume":"174","author":"Falkenburg","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib79","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1172\/JCI118134","article-title":"Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes","volume":"96","author":"Faber","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib80","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2010.02.005_bib81","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib82","doi-asserted-by":"crossref","first-page":"8639","DOI":"10.1073\/pnas.96.15.8639","article-title":"CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells","volume":"96","author":"Bonnet","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib83","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2007-06-096313","article-title":"DDX3Y encodes a class I MHC-restricted H-Y antigen that is expressed in leukemic stem cells","volume":"111","author":"Rosinski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/sj.leu.2404056","article-title":"Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD\/scid mice","volume":"20","author":"Hambach","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.02.005_bib85","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1073\/pnas.0530192100","article-title":"Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia","volume":"100","author":"Marijt","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib86","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.bmt.1704583","article-title":"Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response","volume":"34","author":"Takami","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.02.005_bib87","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1172\/JCI119601","article-title":"Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion","volume":"100","author":"Claret","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib88","first-page":"2052","article-title":"Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells","volume":"8","author":"Zorn","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib89","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.leu.2403572","article-title":"Minor histocompatibility antigen-specific T cells with multiple distinct specificities can be isolated by direct cloning of IFNgamma-secreting T cells from patients with relapsed leukemia responding to donor lymphocyte infusion","volume":"19","author":"Kloosterboer","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.02.005_bib90","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1158\/1078-0432.CCR-09-0199","article-title":"Development of tumor-reactive T cells after nonmyeloablative allogeneic hematopoietic stem cell transplant for chronic lymphocytic leukemia","volume":"15","author":"Nishida","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2003-07-2603","article-title":"Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants","volume":"103","author":"Randolph","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib92","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1600-6143.2008.02374.x","article-title":"Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation","volume":"8","author":"Stern","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bbmt.2010.02.005_bib93","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/79526","article-title":"Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia","volume":"6","author":"Molldrem","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib94","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood-2003-01-0150","article-title":"Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation","volume":"102","author":"Rezvani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib95","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","article-title":"Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells","volume":"88","author":"Molldrem","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib96","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.V90.7.2529","article-title":"Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units","volume":"90","author":"Molldrem","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib97","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2007-03-076844","article-title":"Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia","volume":"110","author":"Rezvani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib98","first-page":"2561","article-title":"Expansion of tumor-specific CD8+ T cell clones in patients with relapsed myeloma after donor lymphocyte infusion","volume":"63","author":"Orsini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib99","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1182\/blood-2006-04-014480","article-title":"Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation","volume":"109","author":"Atanackovic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib100","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1038\/sj.leu.2404838","article-title":"Characterization of graft-versus-leukemia responses in patients treated for advanced chronic lymphocytic leukemia with donor lymphocyte infusions after in vitro T-cell depleted allogeneic stem cell transplantation following reduced-intensity conditioning","volume":"21","author":"Hoogendoorn","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.02.005_bib101","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/leu.2008.90","article-title":"HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia","volume":"22","author":"Rutten","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.02.005_bib102","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood-2009-10-249821","article-title":"Both permissive and nonpermissive HLA-DPB1 mismatches can induce polyclonal HLA-DPB1 specific immune responses in vivo and in vitro","volume":"115","author":"Rutten","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib103","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1182\/blood-2007-06-095265","article-title":"The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation","volume":"110","author":"Shaw","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib104","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1182\/blood-2008-08-171934","article-title":"HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism","volume":"113","author":"Kawase","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib105","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib106","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199501193320303","article-title":"Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy","volume":"332","author":"Mackall","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib107","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1073\/pnas.022634999","article-title":"Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery","volume":"99","author":"Asavaroengchai","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib108","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1126\/science.1083317","article-title":"Defective CD8 T cell memory following acute infection without CD4 T cell help","volume":"300","author":"Sun","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.02.005_bib109","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1182\/blood-2009-05-223412","article-title":"Blocking PD-1 in cancer immunotherapy","volume":"114","author":"Dotti","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib110","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1182\/blood.V99.9.3179","article-title":"Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity","volume":"99","author":"Bollard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib111","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/blood-2006-07-036863","article-title":"Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells","volume":"109","author":"Curti","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib112","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nri2233","article-title":"Creating immune privilege: active local suppression that benefits friends, but protects foes","volume":"8","author":"Mellor","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib113","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.4049\/jimmunol.0900986","article-title":"IDO activates regulatory T cells and blocks their conversion into Th17-like T cells","volume":"183","author":"Baban","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib114","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.4049\/jimmunol.181.8.5396","article-title":"The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib115","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1126\/science.1465616","article-title":"Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice","volume":"258","author":"Mizoguchi","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.02.005_bib116","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodriguez","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2010.02.005_bib117","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib118","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","article-title":"Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells","volume":"67","author":"Sinha","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib119","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1002\/eji.200939892","article-title":"Myeloid-derived suppressor cells in inflammation: uncovering cell subsets with enhanced immunosuppressive functions","volume":"39","author":"Bronte","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib120","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib121","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","article-title":"Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo","volume":"92","author":"Gabrilovich","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib122","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nm1554","article-title":"IFN-gamma mediates CD4+ T-cell loss and impairs secondary antitumor responses after successful initial immunotherapy","volume":"13","author":"Berner","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib123","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ni.1695","article-title":"Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells","volume":"10","author":"Guimond","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib124","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1126\/science.1122927","article-title":"Selective stimulation of T cell subsets with antibody-cytokine immune complexes","volume":"311","author":"Boyman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.02.005_bib125","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1182\/blood-2007-04-086108","article-title":"Rapid generation of a functional NK-cell compartment","volume":"110","author":"Prlic","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib126","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20071681","article-title":"Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets","volume":"205","author":"Sportes","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib127","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1084\/jem.20082013","article-title":"IL-15 trans-presentation promotes human NK cell development and differentiation in vivo","volume":"206","author":"Huntington","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","article-title":"Interleukin-21: basic biology and implications for cancer and autoimmunity","volume":"26","author":"Spolski","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib129","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1182\/blood-2007-09-113050","article-title":"IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy","volume":"111","author":"Hinrichs","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib130","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1200\/JCO.2005.01.109","article-title":"Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206","volume":"23","author":"Ribas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib131","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/0008-5472.CAN-05-0141","article-title":"Tumor cyclooxygenase-2\/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer","volume":"65","author":"Sharma","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib132","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1158\/0008-5472.CAN-08-4709","article-title":"The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies","volume":"69","author":"Ozao-Choy","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib133","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1","volume":"182","author":"Li","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib134","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-065X.2008.00602.x","article-title":"Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells","volume":"222","author":"Marigo","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2010.02.005_bib135","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.02.005_bib136","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1182\/blood-2009-03-208181","article-title":"Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia","volume":"114","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib137","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI30414","article-title":"Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells","volume":"117","author":"Wrzesinski","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib138","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1172\/JCI10196","article-title":"Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia","volume":"106","author":"Wu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib139","first-page":"5517","article-title":"CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells","volume":"62","author":"Yang","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib140","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1182\/blood.V99.12.4610","article-title":"Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma","volume":"99","author":"Bellucci","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib141","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1182\/blood-2003-07-2559","article-title":"Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens","volume":"103","author":"Bellucci","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib142","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2008-10-183814","article-title":"Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients","volume":"114","author":"Pfistershammer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib143","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1182\/blood-2004-11-4463","article-title":"Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor","volume":"105","author":"Bellucci","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib144","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib145","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1084\/jem.20031560","article-title":"Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation","volume":"199","author":"Zorn","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib146","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0711293105","article-title":"MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma","volume":"105","author":"Jinushi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib147","doi-asserted-by":"crossref","first-page":"15825","DOI":"10.1073\/pnas.0908358106","article-title":"Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation","volume":"106","author":"Ho","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbmt.2010.02.005_bib148","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1182\/blood-2009-04-217430","article-title":"MICA-129 genotype, soluble MICA and anti-MICA antibodies as biomarkers of chronic graft versus host disease","volume":"114","author":"Boukouaci","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib149","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","article-title":"A systematic review of humoral immune responses against tumor antigens","volume":"58","author":"Reuschenbach","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.bbmt.2010.02.005_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-230X(06)95001-5","article-title":"NY-ESO-1: review of an immunogenic tumor antigen","volume":"95","author":"Gnjatic","year":"2006","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib151","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nm0598-627","article-title":"B cells inhibit induction of T cell-dependent tumor immunity","volume":"4","author":"Qin","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2010.02.005_bib152","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1158\/1078-0432.CCR-07-1290","article-title":"High levels of B-cell activating factor in patients with active chronic graft-versus-host disease","volume":"13","author":"Sarantopoulos","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib153","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib154","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1182\/blood-2008-10-161638","article-title":"The role of B cells in the pathogenesis of graft-versus-host disease","volume":"114","author":"Shimabukuro-Vornhagen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib155","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","article-title":"Rituximab for steroid-refractory chronic graft-versus-host disease","volume":"108","author":"Cutler","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib156","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.bmt.1705725","article-title":"Treatment of refractory chronic GVHD with rituximab: a GITMO study","volume":"40","author":"Zaja","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.02.005_bib157","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2009.04.003","article-title":"Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis","volume":"15","author":"Kharfan-Dabaja","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.02.005_bib158","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2010.02.005_bib159","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2010.02.005_bib160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-065X.2006.00460.x","article-title":"Activation and self-tolerance of natural killer cells","volume":"214","author":"Gasser","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bbmt.2010.02.005_bib161","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.bbmt.2010.02.005_bib162","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.4049\/jimmunol.0803900","article-title":"NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model","volume":"182","author":"Joncker","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib163","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","article-title":"NK cell education: not an on-off switch but a tunable rheostat","volume":"30","author":"Brodin","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib164","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib165","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2010.02.005_bib166","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/ni1402","article-title":"Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction","volume":"7","author":"Welte","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bbmt.2010.02.005_bib167","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2005-02-0479","article-title":"The antileukemia effect of HLA-matched NK and NK-T cells in chronic myelogenous leukemia involves NKG2D-target-cell interactions","volume":"106","author":"Sconocchia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib168","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood-2008-05-158253","article-title":"Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib","volume":"113","author":"Yong","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib169","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1182\/blood-2003-01-0091","article-title":"Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors","volume":"102","author":"Giebel","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib170","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2004-04-1441","article-title":"Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias","volume":"105","author":"Beelen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib171","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib172","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","article-title":"Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor","volume":"100","author":"Davies","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib173","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.0001-2815.2004.00182.x","article-title":"The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD","volume":"63","author":"Bishara","year":"2004","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2010.02.005_bib174","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1182\/blood-2003-11-3893","article-title":"Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors","volume":"103","author":"Bornhauser","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib175","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.bbmt.2006.05.007","article-title":"The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European Blood and Marrow Rransplant Registry, and the Dutch Registry","volume":"12","author":"Farag","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2010.02.005_bib176","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1097\/01.tp.0000235859.24513.43","article-title":"Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation","volume":"82","author":"Kroger","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2010.02.005_bib177","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood-2008-07-171926","article-title":"Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia","volume":"113","author":"Cooley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib178","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI0215175","article-title":"T cell homeostatic proliferation elicits effective antitumor autoimmunity","volume":"110","author":"Dummer","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.bbmt.2010.02.005_bib179","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","article-title":"Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes","volume":"298","author":"Dudley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2010.02.005_bib180","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib181","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1182\/blood-2008-12-189266","article-title":"Safety and immunologic effects of IL-15 administration in nonhuman primates","volume":"114","author":"Berger","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2010.02.005_bib182","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bbmt.2010.02.005_bib183","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/14653240902807034","article-title":"Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells","volume":"11","author":"Berg","year":"2009","journal-title":"Cytotherapy"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110000601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879110000601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:36:29Z","timestamp":1761057389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879110000601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":183,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S1083879110000601"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.02.005","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor\/Leukemia Reaction","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2010.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}